RecruitingNCT05254197
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Studying Benign schwannoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seoul National University Hospital
- Principal Investigator
- Chul-Kee Park, MD PhDSeoul National University Hospital
- Enrollment
- 3000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2001 – 2035
Study locations (1)
- Seoul National University Hospital, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05254197 on ClinicalTrials.govOther trials for Benign schwannoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07078136Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor DiagnosisHuazhong University of Science and Technology
- RECRUITINGNANCT05139277Evaluation of the CONVIVO SystemDartmouth-Hitchcock Medical Center
- RECRUITINGNCT05576103Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsJona Hattangadi-Gluth
- RECRUITINGNCT06421805Establishing Prospective Mediastinal Tumor Database of PUMCHPeking Union Medical College Hospital